SCHEMBL3712702

SCHEMBL3712702

O=C(O)c1ccccc1-c1ccc(Cl)cc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.51
ALDH1A1 P00352 3/20 0.50
TP53 P04637 2/20 0.50
HSP90AA1 P07900 1/20 0.50
KMT2A Q03164 2/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
GRIK1 P39086 1/20 0.48
FOLH1 Q04609 1/20 0.47
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NR4A1 P22736 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX12 P18054 1/20 0.44
KDM4E B2RXH2 1/20 0.43
RAB9A P51151 1/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9812925 0.86 FOLH1 (0.57) PTGER1ALDH1A1TP53HSP90AA1KMT2A
SCHEMBL16041577 0.84 PTGER1 (0.62) PTGER1ALDH1A1TP53HSP90AA1KMT2A
SCHEMBL442223 0.83 ALDH1A1 (0.58) PTGER1ALDH1A1TP53HSP90AA1KMT2A
SCHEMBL15918927 0.83 PTGER1 (0.54) PTGER1ALDH1A1TP53HSP90AA1KMT2A
SCHEMBL28462102 0.83 KMT2A (0.51) ALDH1A1KMT2AFOLH1CYP3A4CYP2C9
SCHEMBL1712775 0.81 MYC (0.54) PTGER1ALDH1A1TP53HSP90AA1KMT2A
SCHEMBL23354236 0.80 GRM2 (0.51) PTGER1ALDH1A1TP53HSP90AA1KMT2A
SCHEMBL5099606 0.80 KMT2A (0.64) ALDH1A1KMT2ACA1CA2FOLH1
SCHEMBL7802742 0.79 ALDH1A1 (0.63) PTGER1ALDH1A1TP53HSP90AA1KMT2A
SCHEMBL24225441 0.79 S100A4 (0.36) PTGER1ALDH1A1TP53HSP90AA1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398796-A1 HETEROCYCLIC DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Canada Inc. (CA) 2011-12-28 EP disclosed
US-20110301143-A1 HETEROCYCLIC DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK CANADA INC. (CA) 2011-12-08 US disclosed
WO-2010094126-A1 HETEROCYCLIC DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110301143-A1 HETEROCYCLIC DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, COASY PTGER1 1983/4885ALDH1A1 1696/4885TP53 3759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.